CIK 0001395937
- Large accelerated filer
Syndax Pharmaceuticals Inc
Sign in to watch- Ticker
- SNDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320162505
- Phone
- +1 781-419-1400
- Business address
- 730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $113,716
- in 1 filing, $114K under 10b5-1 plans
Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 25 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-15 | Ordentlich Peter Chief Scientific Officer | Option exercise | +7,572 | $6.38 | $48K | 7,572 |
| 2023-02-15 | Ordentlich Peter Chief Scientific Officer | Sale | −7,572 | $25.84 | $196K | 0 |
| 2023-02-15 | Ordentlich Peter Chief Scientific Officer | Option exercise | +17,428 | $7.20 | $125K | 17,428 |
| 2023-02-15 | Ordentlich Peter Chief Scientific Officer | Sale | −17,428 | $25.84 | $450K | 0 |
| 2023-02-15 | Ordentlich Peter Chief Scientific Officer | Option exercise · Stock Options (Right to buy) | −17,428 | $25.84 | $450K | 0 |
| 2023-02-15 | Ordentlich Peter Chief Scientific Officer | Option exercise · Stock Options (Right to buy) | −7,572 | $25.84 | $196K | 0 |
| 2023-02-02 | Ordentlich Peter Chief Scientific Officer | Grant or award · Stock Options (Right to buy) | +90,000 | $28.55 | $2.6M | 90,000 |
| 2023-02-01 | Ordentlich Peter Chief Scientific Officer | Sale | −69 | $28.43 | $2K | 0 |
| 2023-01-31 | Ordentlich Peter Chief Scientific Officer | Other acquisition | +69 | $17.32 | $1K | 69 |
| 2022-12-02 | Ordentlich Peter Chief Scientific Officer | Option exercise | +17,200 | $6.38 | $110K | 17,465 |
| 2022-12-02 | Ordentlich Peter Chief Scientific Officer | Sale | −17,200 | $25.05 | $431K | 265 |
| 2022-12-02 | Ordentlich Peter Chief Scientific Officer | Option exercise · Stock Options (Right to buy) | −17,200 | 0 | ||
| 2022-12-01 | Ordentlich Peter Chief Scientific Officer | Option exercise | +3,772 | $6.35 | $24K | 4,037 |
| 2022-12-01 | Ordentlich Peter Chief Scientific Officer | Sale | −3,772 | $25.01 | $94K | 265 |
| 2022-12-01 | Ordentlich Peter Chief Scientific Officer | Option exercise | +4,028 | $6.38 | $26K | 4,293 |
| 2022-12-01 | Ordentlich Peter Chief Scientific Officer | Sale | −4,028 | $25.01 | $101K | 265 |
| 2022-12-01 | Ordentlich Peter Chief Scientific Officer | Option exercise · Stock Options (Right to buy) | −4,028 | 0 | ||
| 2022-12-01 | Ordentlich Peter Chief Scientific Officer | Option exercise · Stock Options (Right to buy) | −3,772 | 0 | ||
| 2022-08-24 | Ordentlich Peter Chief Scientific Officer | Option exercise | +22,846 | $6.32 | $144K | 23,111 |
| 2022-08-24 | Ordentlich Peter Chief Scientific Officer | Sale | −22,846 | $25.04 | $572K | 265 |
Page 1 of 3 · 45 trades